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Abstract  The  functional  imaging  of  perfusion  enables  the  study  of  its  properties  such  as  the
vasoreactivity  to  circulating  gases,  the  autoregulation  and  the  neurovascular  coupling.  Down-
stream from  arterial  stenosis,  this  imaging  can  estimate  the  vascular  reserve  and  the  risk  of
ischemia  in  order  to  adapt  the  therapeutic  strategy.  This  method  reveals  the  hemodynamic
disorders in  patients  suffering  from  Alzheimer’s  disease  or  with  arteriovenous  malformationsvasoreactivity;
Autoregulation;
Functional  BOLD  MRI
revealed  by  epilepsy.  Functional  MRI  of  the  vasoreactivity  also  helps  to  better  interpret  the
functional MRI  activation  in  practice  and  in  clinical  research.
© 2013  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
Reminders about cerebral perfusion
The  study  of  cerebral  perfusion  provides  critical  information  to  understand  the  functioning
of  the  central  nervous  system  and  apprehend  its  dysfunction,  among  the  main  causes  of
morbidity  and  mortality  in  the  West.  In  neurology  and  psychiatry,  the  identiﬁcation  of
these  microvascular  pathophysiological  disorders  may  provide  information  that  may  help
to  better  characterize  a several  diseases,  or  even  assess  individual  vulnerability.
Above  all,  cerebral  perfusion  allows  for  the  transfer  of  appropriate  quantities  of  glucose
and  oxygen  for  the  functional  needs  of  the  brain,  while  eliminating  heat  and  some  catabo-
lites  such  as  CO2 [1].  Perfusion  is  a  dynamic  physiological  phenomenon  able  to  respond
to  changes  in  the  homoeostasis  of  the  vascularized  organ  and  the  entire  body.  Like  any
biological  function,  general  and  local  factors  are  likely  to  not  only  modify  its  state  of
equilibrium  but  also  its  adaptive  properties.  This  adjustment  is  both  passive,  due  to  the
Abbreviations: ASL, arterial spin labeling; BOLD, blood oxygenation level dependent; CBF, cerebral blood ﬂow; CBV, cerebral blood
volume; CVR, cerebral vasoreactivity; fMRI, functional MRI; MRA, magnetic resonance angiography; PaCO2, arterial pressure in CO2; PeCO2,
expiratory pressure in CO2.
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echanical  characteristics  of  blood  vessels,  and  active  by
he  arteriolar  vasomotricity.  The  vasomotricity  controls  the
aliber  of  the  arterioles,  so  as  to  maintain  the  blood  supply
uring  variations  in  neuronal  activity  (neurovascular  cou-
ling),  cerebral  perfusion  pressure  (autoregulation),  capnia,
xygenation  and  pH  (vasoreactivity)  [1].
Cerebral  perfusion  may  simply  be  characterized  by  the
erebral  blood  ﬂow  (CBF),  deﬁned  by  the  volume  of  blood
ransiting  by  the  mass  of  the  cerebral  parenchyma  per
nit  of  time  (classically  expressed  in  ml/100  g  of  cerebral
arenchyma/min).  Since  the  density  of  brain  tissue  is  close
o  that  of  water,  the  mass  is  often  converted  into  volume,
llowing  the  CBF  to  be  expressed  as  a  percentage  of  the
arenchyma  perfused  per  second  (s−1)  (Table  1).  The  direct
easurement  of  this  dynamic  property  is  especially  difﬁcult.
his  has  given  rise  to  the  development  of  multiple,  more  or
ess  invasive,  methods  that  can,  more  or  less,  be  consid-
red  in  man.  Numerous  indicators  and  analytic  models,  with
heir  advantages  and  disadvantages,  have  thereby  been  pro-
osed  [1,2].  The  initial  methods,  such  as  those  developed  by
ety  and  Schmidt  with  the  inhalation  of  NO2 [3],  measured
 global  CBF  based  on  the  analysis  of  the  concentration  of
he  marker  at  the  entry  and  exit  from  the  vascular  system.
n  imaging,  the  CBF  is  measured  on  the  scale  of  a cerebral
egion  (rCBF),  or  even  the  pixel  of  a  digital  image  and  the
oxel  with  tomography  techniques.  The  success,  over  the
ast  decades,  of  the  imaging  that  has  been  established  due
o  a  major  reduction  in  the  invasiveness  of  the  procedures
nd  an  increase  in  the  temporal  and  spatial  resolutions,  has
ed  to  assimilate  the  rCBF  with  the  CBF.
The  cerebral  blood  ﬂow  and  the  cerebral  blood  volume
CBV)  are  two  physiologically,  closely  related  parameters,
ince  they  depend  on  the  variations  in  arteriolar  resistance.
he  mechanics  of  the  ﬂuids  proportionally  links  variations  in
he  volume  with  the  square  root  of  variations  in  ﬂow.  In  the
eurosciences,  this  ratio  is  estimated  by:  ([V/Vo]  =  [F/Fo])
Table  1  Basal  cerebral  perfusion  values  usually  admit-
ted  in  man  [1].
Mean  CBF ∼= 60 ml/100  g/min
∼= 60  ml/100  ml/min
(parenchyma
density  =  1.04  g/ml)
∼= 1 ml/100  ml/s
∼= 0.01/s  (or  1%  of  the
parenchyma  corresponds  to
the  fresh  blood  each  second)
CBF  grey  matter  80  ml/100  g/min
CBF  white  matter  20  ml/100  g/min
Density  grey  matter  /
Density  white  matter
∼= 1
CBV  4  ml/100  g ∼= 4%  of  the
parenchyma
∼= 60 ml  of  blood  for  a  1500  g
brain
Arterial  /  capillary  /
venous  CBV  [280]
21%  /  33%  /  46%
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o  and  Fo  representing  the  volume  and  ﬂow  at  the  initial
tate,  and  V  and  F  the  volume  and  ﬂow  at  the  ﬁnal  state.
ith  an  experimental  modulation  of  the  cerebral  perfusion
y  CO2,   was  estimated  as  being  close  to  0.40  in  the  ani-
al  [4—6].  In  man,  values  of    between  0.29  and  0.73  have
een  reported  with  high  regional  disparities  [7,8].  These
eterogeneities  are  likely  to  reﬂect  differences  between
he  methods  of  measurement  [9],  the  regional  variability
f  the  capillary  density  [10,11],  the  physiological  mecha-
ism  used  to  modulate  the  perfusion  [7,12,13], the  time
nterval  between  the  early  variations  in  the  CBF  that  are
ainly  based  on  the  arteriolar  and  capillary  sectors,  and
ater  variations  in  the  CBV  that  better  reﬂect  the  venous
ector  [6,14,15].
hysiological variations in cerebral
erfusion
t  rest,  the  cerebral  perfusion  decreases  with  age  [16]  and
s  signiﬁcantly  higher  in  women  [17].  The  cerebral  perfusion
s  closely  related  to  the  activity  of  the  brain.  It  is  often  mea-
ured  in  the  neurosciences  and  in  medicine  since  it  reﬂects
he  interaction  between  the  vessels  and  the  neurons  through
eurovascular  coupling.  Moreover,  the  cerebral  perfusion  is
aintained  roughly  constant  in  order  to  deal  with  variations
n  the  blood  pressure  and  intracranial  pressure  by  autoregu-
ation.  The  cerebral  perfusion  is  also  sensitive  to  variations
n  the  arterial  concentration  in  CO2 and  O2 by  the  vasoreac-
ivity  (Fig.  1).  All  of  these  physiological  functions  are  based
n  the  vasomotricity  that  enables,  through  the  dilation  and
ontraction  of  the  vessels,  to  adjust  the  cerebral  blood  ﬂow
n  order  to  guarantee  the  cerebral  activity  by  dealing  with
he  general  and  local  physiological  constraints  [18].
nnervation of cerebral vascularization
xtrinsic  innervation
he  extrinsic  vascular  innervation  of  the  pial  arteries  arrives
rom  the  peripheral  nervous  system  by  the  upper  cervi-
al,  sphenopalatine,  trigeminal  and  optical  ganglions  that
elay  the  information  from  peripheral  baroreceptors.  The
xtrinsic  innervation  is  mainly  sympathetic  vasoconstrictor
noradrenalin,  serotonin,  neuropeptide  Y)  and  parasympa-
hetic  vasodilator  (acetylcholine,  nitric  oxide,  VIP).  The
rteries  progressively  divide  into  arterioles  that  enter  the
erebral  parenchyma.  They  consist  of  an  internal  layer  of
ndothelial  cells,  smooth  muscle  cells  and  an  outer  layer
f  leptomeningeal  cells  that  form  the  external  tunic.  The
rteriole  is  separated  from  the  parenchyma  by  the  Virchow-
obin  space  that  contains  the  cerebrospinal  ﬂuid  and  is
ordered  by  astrocytes  on  the  outside.  As  the  arterioles
nter  the  parenchyma,  the  ﬂuid  space  disappears  and  the
rterioles  and  then  the  capillaries  are  in  direct  contact
ith  the  feet  of  the  astrocytes  that  form  the  glia  limitans
19—21].ntrinsic  innervation  and  the  neurovascular  unit
he  intrinsic  innervation  of  the  intra-parenchymatous  arte-
ioles  by  the  central  nervous  system  relies  on  cortical
nterneurons  and  the  efferences  of  subcortical  neurons
Functional  imaging  of  cerebral  perfusion  1261
Figure 1. Functional variations in cerebral perfusion and BOLD
signal. The full arrows represent a positive relationship and the
dotted arrows a negative relationship. The arteriolar caliber is
modulated by the neurovascular coupling induced by the neuronal
activity, the vasoreactivity to O2 and, above all, CO2, the autoregu-
lation of the perfusion pressure (that is, the difference between the
mean arterial pressure and the intracranial pressure). The increase
in the cerebral blood ﬂow (CBF), higher than the cell needs, reduces
the oxygen extraction fraction (OEF) and increases the cerebral
blood volume (CBV) which reduces the deoxyhemoglobin content
(deoxyHb) in the voxel. Since the deoxyHb is paramagnetic, it short-
Table  2  Main  vasoactive  substances  [20].
Vasomotor  effect
Ions
K+ Dilation
H+ Dilation
Metabolites
CO2 Dilation
O2 Constriction
Adenosine  Dilation
Neurotransmitters
Acetylcholine  Dilation
Noradrenalin  Constriction
Serotonin  Constriction
Dopamine  Dilation  (D1/D5  receptor)
Constriction  (D2/D3/D4  receptor)
GABA  Dilation
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These  elements  underline  the  close  anatomo-functionalens the T2. This reduction increases the signal in imaging sensitive
to the BOLD effect.
coming  from  the  nucleus  basalis  of  Meynert  and  the
frontobasal  region  (acetylcholine),  the  locus  coeruleus  (nor-
adrenalin)  and  the  raphe  nuclei  (serotonin).  The  action  of
the  GABAergic  cortical  interneurons  may  contract  or  dilate
the  vessels.  Whereas  GABA  is  a  vasodilator,  the  activity  of
these  interneurons  is  modulated  by  a  speciﬁc  subcortical
innervation.  The  subcortical  efferences  directly  innerve  the
vascular  wall  and  the  astrocytes.  Other  vasomotor  neuro-
transmitters  such  as  dopamine  coming  from  the  ventral
tegmental  area  (black  matter)  may  also  act  by  direct  vascu-
lar  innervation  or  through  the  innervation  of  the  astrocytes
(Table  2)  [22,23].
At the  capillary  level,  the  structural  association  of
the  pericytes  edged  by  the  feet  of  the  astrocytes  inner-
vated  by  cortical  interneurons  and  subcortical  neurons
form  a  ‘‘neuron-astrocyte-vasculature  tripartite  functional
unit’’,  more  commonly  called  ‘‘neurovascular  unit’’  [19].
The  essential  role  of  the  astrocytes  in  the  vasodilation
induced  by  neuronal  activity  has  recently  been  demon-
strated  [24—26].  In  addition,  the  integrity  of  the  glia  limitans
is  required  for  arteriolar  vasodilation  [27].
Neurovascular coupling
Cerebral  perfusion  is  closely  related  to  neuronal  activ-
ity.  This  global  and  local  adaptation  of  cerebral  perfusion
extensively  relies  on  the  perivascular  innervation  and  the
neurovascular  unit.  Therefore,  the  perfusion  is  currently
r
i
tNO  Dilation
easured  in  the  neurosciences  and  in  medicine  since  it  is
he  direct  reﬂection  of  the  interaction  between  the  vessels
nd  the  neurons.
The  increase  in  perfusion  is  related  to  the  energy  activity
f  the  brain.  In  man,  75%  of  the  energy  intake  is  consumed
y  post-synaptic  activity,  7%  by  pre-synaptic  activity,  10%
y  the  neuron  action  potential,  6%  by  the  astrocyte  activity
nd  2%  by  the  transmembrane  resting  potential  [28].  The
euron  energy  metabolism  is  based  on  the  use  of  the  oxy-
en  and  glucose  carried  by  the  blood  to  the  capillaries  [29].
he  increase  in  synaptic  activity  results  in  a  reduction  in
he  oxyhemoglobin  (HbO2) concentration  and  an  increase  in
hat  of  deoxyhemoglobin  (deoxyHb).  This  initial  dip  in  blood
xygenation  before  the  hemodynamic  response  may  be  the
ost  reliable  marker  of  the  neuronal  activity  [30], although
ts  demonstration  using  BOLD  fMRI  is  unpredictable.
Functional  hyperhemia  occurs  1  to  2  s after  the  begin-
ing  of  the  neuronal  activity.  Although  the  local  increase
n  CFB  is  proportional  to  the  glucose  consumption  [31],  the
xygen  intake  is  abnormally  high  compared  with  the  mod-
rate  increase  in  its  capillary  extraction.  In  addition,  the
yperhemia  covers  a  wider  zone  than  that  of  the  neuronal
ctivity  [32].  The  time  before  the  hemodynamic  response,
he  inadequacy  between  the  needs  in  glucose  and  the  oxy-
en  intake  and  the  early  release  of  lactate  have  suggested
hat  the  glycolysis  may  initially  be  anaerobic  by  the  use  of
he  glycogen  delivered  by  the  astrocytes,  and  more  quickly
seable  than  the  capillary  glucose  that  will  be  used  subse-
uently.  Therefore,  the  release  of  glutamate  in  the  synaptic
pace  would  lead  to  an  astrocyte  recapture  that  metabolizes
t  into  glutamine  by  anaerobic  glycolysis,  then  delivered
o  the  neuron.  As  for  the  lactate,  it  would  be  aerobically
etabolized  by  the  neuron  to  supply  the  ATP  required  for
onic  re-equilibrium  following  the  neuronal  depolarization
29,33].elationship  between  the  neurons,  vessels  and  astrocytes
n  neurovascular  coupling.  Its  proper  operation  relies  on
he  structural  integrity  of  the  constituents  (anatomic,
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istological  and  cellular),  an  appropriate  release  and
oncentration  of  vasoactive  agents,  as  well  as  the  integrity
f  their  action  mechanisms.
From  this,  the  idea  progressively  emerges  that  there  may
e  diseases  of  the  neurovascular  unit,  such  as  Alzheimer’s
isease  [19,20,34—37].
utoregulation of cerebral pressure
utoregulation  helps  maintain  the  cerebral  pressure  signiﬁ-
antly  constant  by  adjusting  the  arteriol  dilation  according
o  the  variations  in  the  perfusion  pressure  (PP),  deﬁned  by
he  difference  between  the  mean  arterial  pressure  (MAP)
nd  the  intracranial  pressure  (ICP),  PP  =  MAP-ICP.  When  the
erfusion  pressure  increases  due  to  an  increase  in  arterial
ressure,  the  autoregulation  induces  a  vasoconstriction,  in
rder  to  avoid  the  risk  of  the  rupture  of  the  brain-blood  bar-
ier  (BBB)  and  tissue  edema,  or  even  hemorrhage.  When  the
erfusion  pressure  decreases  due  to  a  drop  in  the  arterial
ressure,  the  autoregulation  induces  vasodilation  in  order
o  avoid  the  risk  of  ischemia.  When  the  perfusion  pressure
ecreases  due  to  an  increase  in  the  intracranial  pressure,
he  autoregulation  induces  vasodilation  to  avoid  the  risk  of
schemia.
The  autoregulation  that  adjusts  the  arteriolar  resistances
ccording  to  the  transmural  pressure  gradient  is  maintained
y  the  vascular  muscle  response  to  the  perfusion  pressure  by
he  myotatic  reﬂex  and  the  extrinsic  vascular  innervation.
he  limits  of  the  autoregulation  may  be  modiﬁed  by  the
ympathetic  activity,  the  arterial  pressure  in  CO2,  chronic
rterial  hypertension  and  certain  drugs  [38—40].
The  monitoring  of  the  autoregulation  is  very  important  in
edicine,  in  particular  in  traumatic  disorders,  since  the  loss
f  autoregulation  and  vasoreactivity  to  CO2 are  elements
ointing  to  a  poor  prognosis  [38,39,41—45].
asoreactivity to circulating gases
asoreactivity  to  CO2
he  effects  of  CO2 on  cerebral  vascularization  have  been
bserved  for  a  long  time  and  the  inhalation  of  5  and  10%
olume  fraction  CO2 are  accompanied  by  a  50  and  100%
ncrease  in  CBF,  respectively  [46].  The  CBF  variation  curve
s  a  function  of  PaCO2 is  a  sigmoid  with  an  approximately
inear  portion  for  the  physiological  values  of  the  CBF.  As  of
ormocapnia  (PaCO2 =  about  40  mmHg),  the  hypercapnia  is
ccompanied  by  an  increase  in  the  CBF  and  CBV  of  6%  and
%/mmHg  de  PaCO2,  respectively,  while  the  hypocapnia  is
ccompanied  by  a  reduction  in  the  CBF  and  CBV  of  3%  and
%/mmHg  PaCO2 respectively  [7,47—49].  The  transcranial
oppler  measurement  of  the  arterial  speed  is  used  to  calcu-
ate  the  CO2 vasoreactivity  index,  which  corresponds  to  the
lope  of  the  curve  that  describes  the  mean  arterial  speed  as
 function  of  the  expiratory  pressure  of  CO2.  In  healthy  sub-
ects,  this  index  is  close  to  1.5  cm.s−1.mmHg−1 [50].  This
ascular  response  predominates  on  the  small  caliber  arte-
ioles  —  40—100    [51,52]  —  but  all  vessels,  including  the
apillaries  and  venules  are  involved  [51,53].
Several  mechanisms  have  been  proposed  to  account  for
he  CO2 vasoreactivity.  It  seems  that  the  modiﬁcation  in
he  perivascular  pH,  induced  by  the  free  passage  of  CO2
a
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hrough  the  BBB  and  the  production  of  H+  ions  (CO2 +  H2O  →
+ +  HCO3−),  plays  a  preponderant  role  [54,55], since  HCO3−
s  used  for  the  clearance  of  excess  lactic  acid  produced  by
he  neurons  and  glial  cells  [54].  The  role  of  NO  in  the  CO2
asoreactivity  has  also  been  proposed  [56].  In  physiological
onditions,  its  action  is  modest  [18]. However,  in  pathologi-
al  conditions  (diabetes,  AHT),  the  endothelial  dysfunction
nd  the  poor  distribution  of  NO  account  for  the  alteration  in
he  CO2 vasoreactivity  of  patients.  The  administration  of  an
‘NO  donor’’,  sodium  nitroprussiate,  would  restore  the  CO2
asoreactivity  [50].  The  role  of  the  prostaglandins  has  been
emonstrated  in  certain  animal  species,  but  not  in  man  [18].
Physiological  variations  have  been  described  with  a
educed  vasoreactivity  in  women  [57],  the  elderly  subject
58]  and  during  the  early  hours  of  the  day  [59,60].
2 vasoreactivity
he  vascular  effects  of  O2, as  opposed  to  those  of  CO2,
ave  also  been  known  for  several  decades  [61]. Hypoxemia
ccompanies  an  increase  in  the  CBF,  whether  due  to  hypoxia
by  a  reduction  in  the  O2 intake),  anoxia  (by  the  inhalation
f  carbon  monoxide  (CO)  that  saturates  the  Hb  in  HbCO)
r  anemia  (by  a  reduction  in  the  functional  Hb  concen-
ration).  However,  this  effect  is  observed  for  pathological
alues  of  PaO2 under  60  mmHg  (threshold  of  respiratory
nsufﬁciency),  while  the  normal  PaO2 is  close  to  90  mmHg
18,49,62]. The  mechanisms  responsible  for  the  cerebral
asodilation  with  hypoxia  are  still  poorly  known.  Vascular
nnervation  and  the  peripheral  baro  or  chemoreceptors  are
ot  involved.  However,  the  ventrolateral  region  of  the  bulb
s  sensitive  to  hypoxia  and  its  destruction  alters  the  vasodi-
ation  at  hypoxia  without  modifying  the  CO2 vasoreactivity
63]. Another  analogous,  more  caudal  region  has  also  been
escribed.  Adenosine  may  be  the  mediator  of  this  vasodila-
ion  during  mild  hypoxia  while  the  H+ and  K+ ions  may  play
 role  in  case  of  severe  hypoxia  [18,64,65].  Finally,  chronic
ypoxia  provokes  structural  modiﬁcations  in  the  microvas-
ular  walls  and  angiogenesis  that  reduces  the  intercapillary
istance  [66].  In  a  recent  experimental  study  carried  out  in
dults  exposed  to  prolonged  hypoxia  by  residing  at  4400  m,
e  observed  an  increase  in  the  cerebral  perfusion  associated
ith  an  alteration  in  the  vasoreactivity  [67].
Normobaric  hyperoxia,  obtained  by  the  inhalation  of  85
o  100%  O2, induces  a  vasoconstriction  responsible  for  a  7  to
1%  reduction  in  the  CBF  [61,64,68—71],  or  even  an  increase
n  the  CBF  [72].  The  effects  of  hyperoxia  on  cerebral  per-
usion  are  signiﬁcant  for  a  PaO2 superior  to  300  mmHg  [61].
he  reduction  in  the  PaCO2 concomitant  with  the  inhala-
ion  of  O2 may  increase  the  reduction  in  CBF.  The  vascular
ffects  of  hyperoxia  would  be  due  to  the  inactivation  of  the
O-dependent  vasodilation  by  an  increase  in  the  O2-  free
adicals  [73].
unctional imaging of cerebral perfusion
he  functional  imaging  of  cerebral  perfusion  may  be  deﬁned
s  the  study  in  imaging  of  the  functional  variations  in
erebral  perfusion  induced  by  vasomotor  stimuli.  We  have
een  that  the  perfusion  was  physiologically  modiﬁed  by  the
euronal  activity  (neurovascular  coupling),  the  intracranial
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BFunctional  imaging  of  cerebral  perfusion  
perfusion  pressure  (autoregulation),  the  CO2 level  in  the
blood  and,  to  a  lesser  extent,  the  O2 level  (vasoreactivity)
(Fig.  1).  According  to  the  temporal  resolution  of  the  tech-
niques,  we  have  measurements  at  the  state  of  equilibrium,
or  of  the  hemodynamic  response  to  the  vasomotor  stimulus
over  time.
Inﬂuence of the initial conditions
The  functional  variations  of  cerebral  perfusion  may  be  inﬂu-
enced  by  the  initial  conditions.  Insofar  as  the  basal  cerebral
perfusion  reﬂects  the  initial  dilation  of  the  arterioles  and,
as  long  as  the  structural  and  functional  integrity  of  the  arte-
riolar  system  is  preserved,  we  can  intuitively  think  that
the  variation  in  perfusion  induced  by  a  vasomotor  stimu-
lus  is  inversely  proportional  to  the  initial  perfusion.  This
functional  aspect  of  the  perfusion  was  above  all  studied
with  neurovascular  coupling.  The  polemics  that  opposes  the
proportional  model  [74—79]  with  the  additive  model  that
defends  the  independence  of  the  variations  in  perfusion  of
the  initial  conditions  [80—85]  has  not  been  solved  [72,86].
Increases  in  the  BOLD  signal  and  the  CBF  tend  towards  maxi-
mum  values.  The  extreme  experimental  conditions  required
to  reach  them  are  far  from  the  physiological  conditions.  This
does  not  guarantee  the  validity  of  the  physiological  models
usually  used  in  such  conditions  [72].  Even  pharmacologi-
cal  challenge  using  neuromediator  (e.g.,  L-DOPA  a  regional
vasodilator)  failed  to  demonstrate  signiﬁcant  change  of  the
hemodynamic  response  to  hypercapnic  stimuli  using  BOLD
contrast  [87].
Although,  the  relationship  between  the  basal  conditions
of  perfusion  and  the  hemodynamic  response  to  the  CO2
vasoreactivity  has  not  been  studied  as  extensively  as  that
of  the  neurovascular  coupling,  it  seems  necessary  to  have
a  good  assessment  of  the  basal  cerebral  perfusion.  Ideally
quantitative,  this  measurement  may  be  semi-quantitative  in
patients  with  anatomic  hypotheses.
Imaging of the neurovascular coupling
Imaging  of  neurovascular  coupling  is  one  of  the  main  meth-
ods  in  functional  neuroimaging.  Among  other  techniques,
BOLD  fMRI  contrast  is  based  on  the  modiﬁcations  in  cere-
bral  oxygenation  following  that  of  the  synaptic  activity  and,
above  all,  that  of  the  perfusion  that  is  induced  by  the
neurovascular  coupling  (Fig.  1).  This  approach  privileges
the  control  of  the  neuronal  activity  that  determines  the
regressor  of  an  observed  vascular  signal.  The  changes  in
the  hemodynamic  response  are  therefore  interpreted  as  the
consequence  of  those  of  the  neuronal  activity.  The  close
relationship  between  the  synaptic  activity  and  BOLD  sig-
nal,  demonstrated  in  the  animal,  its  non-invasive  nature  and
reproducibility,  have  made  the  fMRI  become,  within  several
years,  the  most  used  technique  in  functional  neuroimaging
[88,89].
The  neuronal  activity  associated  with  a  cognitive  task  is
accompanied  by  an  arteriolar  vasodilation  and  an  increase  in
the  regional  cerebral  blood  ﬂow  (rCBF),  leading  to  vasodila-
tion  of  the  venules  and  veins  due  to  their  elasticity  (balloon
model)  [90,91].  In  addition,  the  exaggerated  increase  in  oxy-
gen  intake  in  the  blood  ﬂow  induces  hyperoxygenation  of  the
venous  blood,  reﬂected  by  an  increase  in  the  oxyhemoglobin
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oncentration  and  a reduction  in  the  deoxyhemoglobin
oncentration.  Now,  deoxyhemoglobin  is  paramagnetic.  By
ltering  the  homogeneity  of  the  intra  and  perivascular  mag-
etic  ﬁeld,  the  deoxyhemoglobin  decreases  the  intensity  of
he  free  induction  decay  observed  in  T2*-weighted  gradient
cho  that  is  a  true  endogenous  contrast  agent.  Thereby,  in
esponse  to  neuronal  activity,  the  reduction  in  the  deoxy-
emoglobin  concentration  is  accompanied  by  an  increase
f  several  percentages  in  the  T2*-weighted  signal  (Fig.  1)
89,92].
The  estimate  of  the  neuronal  activity  from  the  analy-
is  of  the  BOLD  signal  is  based  on  the  hypothesis  that  their
elationship  is  approximately  linear,  which  does  not  exclude
omplex  non-linear  relationships  and  interactions  between
he  different  elements  in  this  relationship.  This  hypothesis
as  backed  up  by  several  experiments  coupling  fMRI  with
ifferent  electrophysiological  methods  [88].
In  spite  of  many  approximations,  the  location  of  the
euronal  activity  by  BOLD  fMRI  was  experimentally  vali-
ated  in  the  animal  [88]  and  in  clinical  practice  by  the
omparison  with  the  evoked  potentials  [93],  the  magneto-
ncephalography  [94], the  pre-  and  per-surgical  stimulations
95—97]  and  lesion  studies  [98—100].
However,  the  relationship  between  the  neuronal  activ-
ty  and  the  BOLD  signal  is  very  indirect  and  is  inﬂuenced
y  multiple,  often  interdependent,  physiological  factors
101,102].  The  BOLD  signal  has  been  shown  to  be  sensi-
ive  to  the  quality  and  intensity  of  the  neuronal  response
o  the  stimulus  [103,104],  to  the  basal  conditions  of  per-
usion  [74—76,80,85],  to  the  blood  oxygenation  [105—107],
o  the  capnia  [108], to  the  vasoreactivity  [109—112].  . . In
ddition,  it  is  advisable  to  add  variations  in  the  general  fac-
ors  to  these  sources,  that  may  inﬂuence  them  such  as  age
58,75,113—115],  sex  [17],  the  consumption  of  substances
uch  as  caffeine  [116—118],  alcohol  [119],  neuroleptics
120,121],  apomorphine  in  patients  with  Parkinson’s  disease
 [122],  anesthetic  products  [123,124]  or  products  modulat-
ng  the  activity  of  neurotransmitters  [125].
In  pathological  conditions,  a  modiﬁcation  in  the  BOLD
ignal  was  observed  in  the  presence  of  transient  arte-
ial  hypertension  [126,127],  arterial  stenosis  [111,128—130],
icro-angiopathy  [110,128], migraine  [131],  multiple  scle-
osis  [132], Alzheimer’s  disease  [75,133]  and  near  a
acroscopic  lesion  such  as  a  stroke  [109,110,134],  tumor
112,135—140], arteriovenous  malformation  [137,141,142].
he  pathophysiology  of  these  BOLD  signal  variations  is  highly
aried,  insofar  as  these  disorders  may  have  an  overall  or
ocoregional  inﬂuence  on  the  basal  CBF,  neurovascular  cou-
ling  and  vasomotricity.
Several  alternatives  have  been  proposed  for  a  better  esti-
ate  of  the  neuronal  activity  in  MRI.  However,  they  are
ased  on  the  measurement  of  the  vascular  effects  of  the
euronal  activity.  Perfusion  imaging  by  arterial  spin  labeling
llows  for  the  dynamic  and  repeated  measurement  of  the
ariations  in  perfusion  induced  by  cognitive  activity,  with
n  excellent  topographic  characterization.  However,  the
ignal-noise  ratio  remains  low  [143—145].  The  quantitative
OLD  fMRI  allows  for  the  calculation  of  the  oxygen  consump-
ion  by  the  neurons,  by  associating  the  conventional  BOLD
MRI  with  a  conventional  and  simultaneous  measurement  of
he  BOLD  and  CBF  signals  modulated  by  a  vasodilation  test
sing  CO2 inhalation  [81,146,147].
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Therefore,  to  interpret  the  BOLD  fMRI  of  the  neurovas-
ular  coupling,  it’s  important  to  have  an  estimate  of  the
asal  value  and  the  functional  variations  in  the  cerebral  per-
usion  (Fig.  2).  This  aspect  becomes  especially  essential  in
EG-fMRI.  In  fact,  the  modiﬁcations  in  the  hemodynamic
esponse  to  abnormal  neuronal  activity  in  epileptogenic
ones  should  be  taken  into  account  in  order  to  identify  these
egions.  Without  these  adjustments,  the  risk  of  localization
rror  would  be  too  high  to  consider  the  clinical  use  of  the
EG-fMRI  [148].
maging of autoregulationhe  autoregulation  of  perfusion  pressure  is  an  important
unction  to  monitor  when  there  is  intracranial  hypertension,
n  particular  during  a  serious  traumatic  brain  injury.  Taking
nto  account  the  risks  related  to  the  transport  of  heavily
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igure 2. False negatives in fMRI activation induced by modiﬁcations 
ear the functional cortex. If absent, an alteration in the perfusion an
esults. A—D. Patient with a left precentral arteriovenous malformatio
rimary sensorimotor activation (A), while the movements of the right h
B). The mapping of the cerebral blood volume reveals locoregional hyp
rojection of the precentral cortex (D). E—H. Patient with a gangliogliom
E, F), inverted activation is detected in projection from the primary m
asoreactivity (F). After the surgery, there is a pseudo-recovery of the
atient with a recurrence of xanthoastrocytoma of the left precentral gy
acial palsy. Before surgery (I, J), the movements of the lips did not allow
pposed to the healthy hemisphere (I). The mapping of the vasoreactivi
ed, with an inverted response around the lesion in blue, masking the fu
f the ipsitumoral primary sensorimotor activation (K), associated with nA.  Krainik  et  al.
quipped  subjects  outside  of  intensive  care,  the  autoreg-
lation  may  be  assessed  with  the  transcranial  Doppler
38,41,45,149]. To  experimentally  modulate  the  perfusion
ressure,  compression  cuffs  may  be  used  on  the  thighs.  A
ystemic  hypotension  is  provoked  by  suddenly  releasing  the
ressure.  The  autoregulation  then  induces  vasodilatation  in
eaction  to  the  drop  in  perfusion  pressure  [150].
However,  studies  on  the  imaging  of  autoregulation  are
are  and  remain  experimental  [126].
maging of vasoreactivityhe  imaging  of  cerebral  vasoreactivity  is  another  approach
or  the  functional  imaging  of  cerebral  perfusion.  As  opposed
o  the  imaging  of  neurovascular  coupling  that  privileges  the
tudy  of  the  neuronal  activity,  the  imaging  of  the  cerebral
in perfusion. In fMRI, an increase in the BOLD contrast is expected
d its functional properties may be the cause and lead to negative
n. The movements of the left hand are accompanied by a right
and are not accompanied by a left primary sensorimotor activation
erperfusion due to the lesion (C), with inverted vasoreactivity in
a of the right precentral gyrus without facial palsy. Before surgery
otor cortex next to the tumor (E), related to an inversion of the
 activation (G), with normalization of the vasoreactivity (H). I—L.
rus, manifested by seizures of the right hemiface. No pre-surgical
 the activation of the ispitumoral primary sensorimotor cortex, as
ty to hypercapnia shows an extensive positive vascular response in
nctional cortex (J). The post-surgical fMRI shows pseudo-recovery
ormalization of the vasoreactivity (L) [139].
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The  imaging  of  cerebral  vasoreactivity  shows  an  improve-Functional  imaging  of  cerebral  perfusion  
vasoreactivity  privileges  the  study  of  a  non-neuronal  vaso-
motor  stimulus,  such  as  CO2 or  acetazolamide.
In  normal  conditions,  the  vasoreactivity  is  inﬂuenced  by
sex  [151],  age  [58,152],  arterial  pressure  [153],  basal  per-
fusion  conditions  [106,152,154,155],  anesthetic  [106,156],
modulation  of  the  action  of  vasomotor  neuromediators,  such
as  that  shown  for  acetylcholine  [157,158],  but  not  for  nor-
adrenalin  [159]  or  dopamine  [87].
The  vasoreactivity  is  greater  in  the  grey  matter  than  in
the  white  matter  [9,84,108,160—166].  Within  the  grey  mat-
ter,  there  are  regional  variations  that  may  be  under  the
inﬂuence  of  variations  in  the  microvascular  density  [10,11]
and  the  heterogeneous  distribution  of  vasomotor  neurome-
diators  [101].  However,  the  published  results  often  differ
and  do  not  provide  an  exact  idea  about  these  regional  vari-
ations.  Therefore,  the  vasoreactivity  of  the  cerebral  cortex
is  greater  than  that  of  the  cerebellum  [163,164]  or  inversely
[7],  than  that  of  the  basal  ganglia  [163,164,167]  except  for
the  thalamus  [166]  or  inversely  [168].  .  .  Differences  have
also  been  reported  within  the  cerebral  cortex,  with  a  more
marked  vasoreactivity  in  the  occipital  and  frontal  lobes
[163,164]  although  this  is  not  constant  [166,169].
In  pathological  conditions,  global  alterations  in  the
hemodynamic  response  have  been  observed  with  chronic
arterial  hypertension  [50,170],  diabetes  [50,171—173],
sepsis  [174],  the  administration  of  certain  antihyperten-
sive  drugs  [175],  opioid  agonists  [176],  in  the  presence
of  diffuse  intracerebral  factors  such  as  microangiopathy
[128,177—179],  transient  global  amnesia  [154],  CADASIL
[180,181],  normal  pressure  hydrocephalus  [182],  traumatic
brain  injury  [38,39,41—45,183,184],  Alzheimer’s  disease
[185—189].  .  .  Locoregional  variations  are  also  observed
downstream  from  arterial  stenosis  [111,128,129,190—198],
in  focal  epilepsy  [199—201]  and  near  a  macroscopic  lesion,
such  as  a  stroke  [109,110,202],  an  arteriovenous  malforma-
tion  (Fig.  2)  [141,203]  or  a  tumor  [112,139,140].
Value of the measurement of the cerebral
vasoreactivity
Value of neurovascular coupling for functional
imaging
The  different  functional  imaging  techniques  for  cognition,
such  as  BOLD  fMRI,  are  mainly  based  on  neurovascular  cou-
pling.  However,  in  spite  of  obvious  modiﬁcations  in  the  BOLD
signal  in  patients,  almost  all  of  the  studies  do  not  take
into  account  possible  intra-  and  inter-individual  variations  in
the  physiological  mechanism  at  the  origin  of  the  measured
signal.  During  the  interpretation  of  the  BOLD  signal,  it  is
therefore  impossible  to  distinguish  the  speciﬁc  effects  of  the
variations  in  neuronal  activity  from  variations  in  the  hemo-
dynamic  response  or  a  possible  interaction  between  these
two  factors.  This  represents  an  obvious  limit  to  the  tech-
nique  that  has  to  be  overcome  in  order  to  better  interpret
fMRI  results  [101,109,112,139,140].The  evaluation  of  the  hemodynamic  response  is  obtained
by  the  test  of  vasoreactivity  to  CO2,  even  though  the
mechanisms  involved  differ.  In  spite  of  this  physiologi-
cal  approximation,  the  normalization  of  the  neurovascular
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OLD  signal  by  a  hypercapnia  test  is  at  the  base  of  the
uantitative  fMRI  [76,162,204]. This  approach  consists  of
imultaneously  measuring  the  BOLD  signal  and  the  cere-
ral  blood  ﬂow.  These  parameters  provide,  by  hypercapnia
alibration  of  a  biophysical  model  of  the  BOLD  signal,  the
elative  quantiﬁcation  of  the  consumption  of  oxygen  by
he  cerebral  parenchyma  [81,146,147,205].  From  then,  this
ethod,  in  the  cognitive  neurosciences,  allows  for  compari-
on  of  the  intra-  and  inter-individual  data  to  better  estimate
he  modiﬁcations  induced  by  aging,  neurodegenerative  dis-
ase,  disabling  focal  cerebral  lesions  (epilepsy,  tumor  and
emoval,  ischemic  stroke. . .).
In  clinical  practice,  this  approach  would  allow  for  a
etter  interpretation  of  the  functional  mapping,  in  par-
icular  in  patients  before  surgery,  by  taking  into  account
lterations  in  the  vasoreactivity  near  the  lesions  (Fig.  2)
112,139,140].
rognostic value in steno-occlusive disease
n  patients  monitored  for  steno-occlusive  disease  of  the  cer-
ical  arteries,  the  measurement  of  the  vascular  reserve  in
he  territory  of  the  damaged  artery  is  used  to  assess  the
isk  of  an  ischemic  stroke  (CVA)  or  a  transient  ischemic
ttack  (TIA).  Downstream  from  an  occlusion  or  severe  steno-
is,  the  reduction  in  perfusion  pressure  is  compensated  by
he  autoregulation  and  vasodilation  that  help  maintain  the
onstant  perfusion.  The  absence  of  additional  vasodilation
ttests  to  the  absence  of  vascular  reserve  to  deal  with  an
ncrease  in  perfusion  required  to  compensate  the  reduction
n  the  blood  supply  (increase  in  the  stenosis,  reduction  in
he  cardiac  output  or  the  arterial  blood  pressure),  thereby
xposing  the  patient  to  arterial  ischemia  [190,206—215].
herefore,  the  study  of  the  vascular  reserve  offers  a  func-
ional  evaluation  of  the  functionality  of  the  vascular  network
ownstream  from  the  stenosis  and  the  available  collaterality
216,217].
The  clinical  value  of  this  imaging  may  be  determinant
n  patients  with  tight  intracranial  arterial  stenosis  in  which
he  treatment  is  highly  debated.  In  fact,  following  an  ini-
ial  ischemic  episode,  the  risk  of  recurrence  under  medical
reatment  may  attain  30  to  40%  after  2  years,  or  even
0%  when  there  are  clinical  signs  of  hemodynamic  disor-
ers  [218]. Currently,  endovascular  treatment  by  stent  is
onsidered  only  following  a  new  ischemic  episode.  This
eing  so,  the  morbidity  related  to  this  treatment  has  called
ts  justiﬁcation  into  question  [219].  Thereby,  the  imag-
ng  of  the  vascular  reserve  may  better  characterize  the
ature  of  a CVA/TIA  in  these  patients.  A  reserve  maintained
ownstream  from  a  stenosis  would  be  in  favor  of  a  throm-
oembolic  CVA/TIA,  while  an  altered  reserve  may  more
eveal  a  CVA/TIA  of  hemorrhagic  origin  [214].  In  patients
ith  tight  intracranial  arterial  stenosis,  this  imaging  may
dentify  patients  at  risk  of  a  failure  of  a  well  carried  out
edical  treatment  and  help  better  select  patients  likely  to
eneﬁt  from  endovascular  treatment  (Figs.  3  and  4) [198].ent,  or  even  normalization,  of  the  vascular  reserve  after
he  surgical  treatment  of  a  carotid  stenosis  [197,220,221],
oyamoya  disease  [195,222—226]  or  tight  intracranial  arte-
ial  stenosis  (Fig.  4).
1266  A.  Krainik  et  al.
Figure 3. Tight intracranial arterial stenosis without reduction of the vascular reserve. A. A 44-year-old man treated for left capsulo-
lenticular infarction revealing tight stenosis of the termination of the ﬁrst portion of the left middle cerebral artery, accompanied by a
post-stenotic aneurism. B. The basal perfusion is normal. C. The vasoreactivity does not show an alteration in the vascular reserve in the
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ell carried out anti-platelet therapy. The aneurism was surgically 
owards imaging of the vasoreactivity for
iagnostic purposes
he  global  and  regional  variations  in  the  cerebral  vasore-
ctivity  observed  in  patients  may  reveal  modiﬁcations  in
he  basal  cerebral  perfusion  [5,8,74],  mechanical  vas-
ular  properties  [180,227],  concentration  of  vasomotor
ubstances  in  the  perivascular  environment,  relations
etween  the  vessels,  astrocytes  and  neighboring  neurons
101].  However,  a  great  many  cerebral  and  cerebrovas-
ular  disorders  are  likely  to  be  accompanied  by  global
nd  locoregional  alterations  in  vasoreactivity,  as  shown  in
atients  [82,109,111,112,128,177,186,192,228]  and  experi-
ental  animal  models  [27,158,180,229—233].
The  potential  ﬁelds  for  the  application  of  the  imaging
f  the  vasoreactivity  for  diagnostic  purposes  are  extremely
ast.  However,  the  imaging  of  the  vasoreactivity  is  only
sed  in  case  of  occlusive  arterial  disease,  in  order  to
ssess  the  vascular  reserve  of  the  cerebral  parenchyma  and
he  risk  of  ischemic  stroke.  The  cerebral  imaging  of  the
asoreactivity  may  be  used  to  search,  in  the  entire  brain,
e
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[boembolic ischemia. A deﬁciency recurrence was not noted under
ed.
nfracentimetric  spatial  anomalies  of  the  functional  mod-
lation  of  the  cerebral  perfusion.  It  would  be  possible  to
stimate  the  sensitivity  and  speciﬁcity  of  these  anomalies
y  comparing  the  results  with  those  obtained  in  controls.
or  diagnostic  purposes,  this  imaging  of  the  microvascular
unction  and  its  interactions  with  the  metabolic,  neuronal
nd  glial  perivascular  environments  may  offer  a  better
henotypic  characterization  of  neurological  and  psychiatric
iseases,  or  even  an  estimate  of  the  individual  vulnerability
o  these  disorders  even  before  the  appearance  of  clinical
igns  or  macroscopically  identiﬁable  lesions  in  imaging.  In
he  same  way  that  the  injection  of  contrast  product  offers
 functional  contrast,  the  imaging  of  the  vasoreactivity  may
ffer  a  functional  contrast  that  should  be  put  to  use  for
edical  purposes.
In neurodegenerative  disease,  three  recent  studies  have
hown  alterations  in  the  vasoreactivity  in  Alzheimer’s  dis-
ase  and  patients  at  risk  [186,188,189],  by  underlining  the
mportance  of  microvascular  disorders  in  the  physiopathol-
gy  of  the  disease,  as  suggested  by  the  data  in  the  animal
234—237]. On  the  other  hand,  in  an  analogous  study  carried
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Figure 4. Tight intracranial arterial stenosis with reduction of the vascular reserve [198]. A. A 63-year-old woman treated for tight
stenosis of the M1 portion of the left middle cerebral artery (arrow), revealed by a deep ischemic stroke. A—C. Pre-surgical examinations.
D—F. Post-surgical examinations. A and D. The angiography shows tight stenosis before (A) and after dilation by stenting (D). B and E.
Basal perfusion MRI measured by arterial spin labeling. The basal perfusion is normal and globally symmetrical, both after and before the
intervention. C and F. BOLD-fMRI of the vasoreactivity to hypercapnia. The fMRI of the vasoreactivity to CO2 shows a major alteration in
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tthe vascular reserve in the territory of the arterial stenosis (C). It o
territory, the intervention normalized the vascular reserve (F).
out  in  patients  monitored  for  idiopathic  Parkinson’s  disease,
we  did  not  ﬁnd  a  signiﬁcant  alteration  in  the  cerebral  vasore-
activity  (Fig.  5)  [87].  In  this  context,  the  normality  of  this
examination  may  be  a  diagnostic  criterion  to  distinguish  it
from  vascular  parkinsonism.
In  epileptology,  perfusion  anomalies  have  been  described
outside  of  seizures,  both  in  the  irritative  cortical  zones
and  in  the  non-epileptic  zones  [200,238].  In  focal  epilepsy,
interictal  basal  hypoperfusion  has  been  reported  with
a  cortico-thalamic  diaschisis  [239].  More  surprisingly,  an
increase  in  the  perfusion  of  the  epileptogenic  cortex  and
hypoperfusion  of  the  healthy  cortex  has  been  identiﬁed  up  to
10  min  before  the  occurrence  of  a  seizure  [240,241].  Beside
w
c
a
Figure 5. Vasoreactivity and neurodegenerative diseases. These illustra
demonstrate that the study of cerebral vasoreactivity to CO2 using BOLD f
Alzheimer’s disease and in a subject at risk with amnestic mild cognitiv
patients with Parkinson’s disease when compared with a healthy subjectsly is a hemodynamic ischemia. Except for the posterior junctional
hese  basal  perfusion  anomalies,  a  reduction  in  the  perinidal
asoreactivity  has  been  detected  in  patients  with  arteriove-
ous  malformations  and  epilepsy  whereas  the  vasoreactivity
as  normal  in  the  absence  of  epilepsy  (Fig.  6) [242].
In  neuro-oncology,  the  BOLD  MRI,  sensitive  to  variations
n  tissue  perfusion  and  blood  oxygenation,  illustrate  the
onsiderable  inter-individual  and  intra-tumoral  variability
243—246].  Therefore,  the  perfusion  imaging  can  show  func-
ional  differences  in  microvascularization  according  to  the
ype  of  tumor.  The  crude  angiogenesis  of  certain  tumors  is
ithout  vasoreactivity,  while  the  angiogenesis  of  others  is
loser  to  normal  cerebral  vascularization  and  have  vasore-
ctivity  [247].
tive cases of subjects about 70 years old, without microangiopathy,
MRI detects diffuse abnormalities in a patient treated for beginning
e impairment (a-MCI) [186], while the vasoreactivity is normal in
 [87].
1268  A.  Krainik  et  al.
Figure 6. Alteration in the vasoreactivity in a patient with an arteriovenous malformation revealed by an epileptic seizure. A. Left
parietal internal arteriovenous malformation (AVM). B. Local hyperperfusion that spares the parietal cortex. C. However, the BOLD-fMRI of
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ﬁhe vasoreactivity to CO2 reveals an alteration in the inferior perin
MV revealed by epilepsy, while the perilesional vasoreactivity in p
In  traumatology,  the  monitoring  of  functional  perfusion
isorders  is  very  important  since  their  occurrence  is  a
oor  prognostic  factor  [38,39,41—45,183,184].  Several  rare
xperimental  trials  have  been  carried  out  by  perfusion
T-scan  with  Xenon  133  [43,248]  or  by  positron  emission
omography  [249].  However,  it  is  legitimate  to  wonder
bout  the  pertinence  of  having  cerebral  mapping  when  the
xpected  anomalies  are  usually  diffuse.  This  is  why  these
arely  ambulatory  patients  are  usually  explored  in  bed  by
ranscranial  Doppler  during  a  modulation  of  the  capnia.
evertheless,  several  difﬁcult  cases  may  be  solved  by  the
egional  anomalies  detected  by  perfusion  MRI  or  perfusion
T-scan  during  a  short  hypercapnia  test.
echniques to measure cerebral
asoreactivity
hoice of imaging method
nitially  studied  in  transcranial  echo  Doppler,  then  in  nuclear
edicine  (PET,  SPECT),  the  imaging  of  the  vasoreactivity
ppeared  in  MRI  several  years  ago,  with  the  development
f  rapid  acquisition  sequences.  Perfusion  tomodensitometry
as  also  been  proposed  [250].
Compared  with  other  imaging  techniques,  MRI  is  available
nd  non-invasive  while  providing  an  image  with  an  infra-
entimetric  spatial  resolution  and  a  temporal  resolution  of
bout  one  second,  which  make  clinical  use  conceivable.  In
ddition,  cerebral  MRI  is  currently  used  in  neurology,  neu-
osurgery  and  psychiatry,  providing  directly  superimposable
unctional  and  morphological  data  during  the  same  exami-
ation.
Several  MRI  methods  have  been  proposed:  BOLD
ontrast  [109,161,225,228,251,252],  ASL  [170,195,215,
16,253—255],  susceptibility  contrast  by  the  injection  of
adolinium  [9,256,257],  magnetic  resonance  angiography
217,258].
In  addition  to  their  availability,  the  multiplicity  of  meth-
ds  attests  to  the  limits  of  each  of  them.  Excluding
acrovascular  imaging  (Doppler,  MRA),  the  calculation  of
m
p
a
dparietal cortex (C). This presentation is described in patients with
ts without epilepsy was normal [203].
he  CVR  is  based  on  the  same  principle  with,  for  variations
n  the  capnia:
CVR  =  signal  (%)/PeCO2 (mmHg)*.
Theoretically,  ASL  is  the  best  method  since  it  allows  the
erebral  blood  ﬂow  to  be  quantiﬁed  and  the  variation  in  its
ignal  may  be  expressed  as  a  ﬂow  variation.  Nevertheless,
SL  requires  careful  methodological  rigor  with  a correction
f  the  T1  effects,  the  choice  of  post-saturation  times  and
 3T  MRI  to  have  a sufﬁcient  signal-noise  ratio  to  detect  a
ariation  of  several  percent  of  this  already  very  low  signal
259].  Moreover,  ASL  with  a  ﬁxed  inversion  time  is  sensitive
o  major  variations  in  the  arterial  transit  time  of  the  labeled
lood  bolus,  distorting  the  quality  of  the  measurement  in
teno-occlusive  disease.  The  current  temporal  resolution  of
ulti-T1  ASL  sequences  does  not  allow  for  dynamic  ASL.
his  being  the  case,  the  acquisitions  with  pseudo-continuous
abeling  cover  the  entire  brain  with  a  resolution  under  10  s,
llowing  for  the  study  of  the  dynamic  variations  in  perfusion
67,216]. Now  and  in  the  absence  of  steno-occlusive  disease,
SL  seems  to  be  the  choice  method  to  study  healthy  subjects
n  physiology  [67]  and  the  cognitive  neurosciences,  patients
resenting  a  neurodegenerative  disease  or  even  children.
owever  and  in  spite  of  these  theoretical  advantages,  the
se  of  ASL  in  this  context  remains  very  marginal  compared
ith  the  increasing  number  of  BOLD  contrast  studies.
Although,  the  BOLD  signal  is  inﬂuenced  by  a  great  many
arameters  (Fig.  1),  this  reproducible  method  is  correlated
ith  variations  in  the  cerebral  blood  ﬂow  [57,260].  We  have
lready  seen  that  variations  in  the  signal  were  sensitive  to
he  basal  perfusion  conditions.  As  a  result,  a  measurement
f  basal  perfusion  either  by  ASL  or  susceptibility  contrast  is
equired  to  make  sure  that  the  differences  in  the  BOLD  sig-
al  variations  are  really  due  to  modiﬁcations  in  the  cerebral
asoreactivity  and  not  simply  the  consequence  of  a  modiﬁ-
ation  in  the  basal  perfusion  [112,186,189].
Perfusion  imaging  by  susceptibility  contrast  during  the
rst  pass  of  a  gadolinium  bolus  may  also  be  proposed.  The
ain  limit  is  the  need  to  inject  two  boluses  of  contrast
roduct,  one  before  the  vasomotor  stimulus  and  the  other
fter.  In  addition,  the  quantiﬁcation  of  the  results  is  still
ifﬁcult,  in  particular  in  the  presence  of  a  rupture  of  the
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brain-blood  barrier.  It  also  lacks  the  measurement  of  hemo-
dynamic  changes  that  might  be  relevant  [112]  because  such
imaging  approach  is  performed  at  two  different  steady-
states.
The  perfusion  CT-scan  is  also  based  on  the  study  of  the
transit  of  a  bolus  of  contrast  product.  The  limits  for  this
approach  are  the  need  to  carry  out  two  examinations,  one
before  the  vasomotor  stimulus  and  the  other  after,  thereby
doubling  the  irradiation  and  the  quantity  of  iodine  injected
[2,250].  The  cover  volume  may  also  be  limited,  although  it
increases  with  the  optimization  of  the  detectors.  The  quan-
tiﬁcation  of  the  perfusion,  easier  than  with  MRI,  and  its  great
availability  may  be  determining  elements  if,  in  the  future,
the  clinical  applications  of  the  imaging  of  the  vasoreactivity
becomes  necessary.
Choice of vasomotor stimulus
In  clinical  practice,  MRI  of  the  vasoreactivity  is  above  all
obtained  by  modulating  the  capnia  either  by  hyperventila-
tion,  apnea,  inhalation  of  CO2 or  injection  of  acetazolamide.
The  study  of  the  vasoreactivity  with  oxygen  is  much  less
developed  since  the  vasomotor  effects  of  oxygen  are  very
low  (see  above)  [64,68—71].
Acetazolamide  (Diamox®)  is  a  carbonic  anhydrase
inhibitor  that  converts  CO2 into  bicarbonates.  It  provokes
hypercapnia  and  acidosis  responsible  for  a  vasodilation  and
an  increase  in  the  CBF  of  about  20  to  30%  [9,80,261].  In  imag-
ing,  15  mg/kg  of  the  product  is  administered  by  intravenous
route  with  a  maximum  of  1200  mg.  The  onset  of  action  is
after  several  minutes.  Its  efﬁcacy  lasts  for  several  hours
before  a  return  to  the  initial  state.  This  product  has  several
contraindications  (kidney  failure,  liver  failure,  allergy. . .)
and  many  secondary  effects  (hydro-electrolytic  disorders,
diabetes,  nephritic  colic. .  .). The  pharmacokinetics  and  the
adverse  effects  of  acetazolamide  limit  its  use  in  imaging  and
in  particular  in  fMRI  [80].  This  stimulus  requires  two  imag-
ing  examinations,  one  before  the  injection  and  the  other  at
least  20  minutes  after  the  injection.  The  intravenous  admin-
istration  of  the  product  and  its  contraindications  limits  its
use  in  healthy  volunteers.
The  sustained  hyperventilation  for  at  least  1 min  induces
hypocapnia  with  a  PeCO2 under  30  mmHg,  that  is  a  reduction
of  10  mmHg  or  more  [8,50,74,82,109,164].  The  hyperventi-
lation  is  accompanied  by  a  vasoconstriction  responsible  for
a  25%  reduction  in  the  CBF  [8,262]  and  a  1  to  5%  drop  in
the  BOLD  signal  [74,82,109,164].  Moreover,  the  hyperventi-
lation  is  responsible  for  tachycardia  without  a  change  in  the
arterial  pressure  [50].
On  the  contrary,  an  apnea  of  at  least  20  s  is  required  to
observe  an  increase  in  the  CBF,  which  may  attain  60%  and
a  1  to  5%  increase  in  the  BOLD  signal  [168,251,263—266].
The  20s  apnea  allows  for  a  7  mmHg  rise  in  the  PeCO2 de
7  mmHg  and  a  45%  increase  in  the  arterial  velocity,  but  it  also
provokes  an  increase  in  blood  pressure,  secondary  hyperven-
tilation  and  transient  hypocapnia.  The  return  to  equilibrium
takes  45  s.  However,  the  hypoxia  does  not  seem  to  affect  the
increase  in  perfusion  [267].The  hyperventilation  and  apnea  are  easy  and  reliable
tasks.  However,  they  induce  movements  of  the  head  and
are  highly  dependent  on  the  sometimes-altered  perform-
ances  of  the  subjects  and,  a  fortiori  of  the  patients  [109].
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oreover,  except  for  sensory  stimulations  (visual  for  exam-
le),  it’s  very  difﬁcult  to  carry  out  an  additional  cognitive
ask  to  study  neurovascular  coupling  in  the  functional
egions  of  motor  skills  or  language.
The  vasodilatation  induced  by  the  inhalation  of  5  to  10%
O2 for  2  to  3  min  is  accompanied  by  an  increase  in  the  cere-
ral  blood  ﬂow  (CBF)  of  2  to  11%,  6%  per  mmHg,  and  the
erebral  blood  volume  of  1.8%  per  mmHg  [7]. Similar  MRI
esults  have  been  observed  with  ASL  [254].  In  BOLD  fMRI,
he  increase  in  cerebral  perfusion  is  accompanied  by  an
ncrease  in  signal  ranging  from  0.2  to  0.3%  per  mmHg  or
—4%  for  an  increase  in  expiratory  pressure  in  CO2 close
o  10—15  mmHg  [87,112,161,186,251,252,268]. The  signal
rogressively  varies  to  reach  a  plateau  after  30—60  s.  A
eturn  to  the  state  of  equilibrium  also  requires  30—60  s
58,76,162,166,167,251].  The  amplitude  of  the  variation  in
ignal  induced  by  the  inhalation  of  CO2 is  roughly  superior
hat  induced  by  the  neurovascular  coupling  that  is  about
.5  to  3%.  This  difference  is  not  due  to  a  sudden  increase  in
euronal  activity  for  a  moderate  hypercapnia  test  [46,269].
Among  the  disadvantages  of  the  inhalation  of  CO2, sev-
ral  minor  adverse  and  rapidly  reversible  effects  should  be
oted.  They  have  been  reported  during  respiratory  function
ests  and  include  mild  headache,  shortage  of  air,  anxiety
r  fatigue  [270—272].  The  anxiogenic  effects  of  the  inhala-
ion  of  CO2 are  experimentally  used  to  provoke  anxiety
isorders,  or  even  panic  attacks,  although  the  appearance
f  such  effects  requires  much  longer  inhalation  protocols
15—20  min)  or  the  use  of  mixtures  more  concentrated  in
O2 (20—35%  CO2) [273,274]. The  mean  arterial  pressure  and
he  pulse  are  stable  for  several  minutes  of  inhalation  [50],
hereas  an  increase  in  these  parameters  may  be  observed
ith  an  inhalation  of  over  10  min  [275].
The  inhalation  of  carbogen  a  7/93%  mixture  of  CO2/O2,
s  an  potential  alternative,  since  there  are  no  reported
ontraindications  or  adverse  effects.  This  aspect  is  readily
sed  in  a  clinical  context  in  brain-damaged  subjects
50,111,182,246]. Carbogen  is  currently  used  in  clinical
ractice,  in  cardiorespiratory  ﬁtness  tests  and  to  test  the
yperventilation  reﬂex  to  hypercapnia.  In  spite  of  the  high
xygen  content,  the  inhalation  of  carbogen  with  over  3%
O2 provokes  a  vasodilation  that  in  turn  induces  an  increase
n  the  arterial  speed  of  about  1.5  cm.s−1.mmHg  PeCO2−1
50]. The  increase  in  the  BOLD  signal  is  2 to  6%  in  the  grey
atter  [87,112,161,186,252]. With  its  high  oxygen  content,
arbogen  also  induces  tissue  hyperoxia.  This  hyperoxia  may
rovoke  an  increase  in  the  BOLD  signal  of  up  to  3%  in  the
rey  matter  [69,246],  in  spite  of  a potential  reduction  of
everal  percent  in  the  CBF  [70].  This  effect  is  accounted
or  by  the  intake  of  freely  diffusible  O2 that  is  directly
sed  by  the  neurons  without  having  to  extract  the  O2 car-
ied  by  the  hemoglobin.  This  results  in  a  reduction  in  the
xygen  extraction  factor  and  the  deoxyhemoglobin  concen-
ration.  This  increase  in  oxygenation  has  to  be  taken  into
ccount  now  that  the  effects  of  carbogen  are  studied  in
OLD  imaging  since,  as  with  the  interpretation  of  neurovas-
ular  coupling,  it’s  difﬁcult  to  distinguish  the  increase  in
erfusion  from  the  local  increase  in  oxygenation  (Fig.  1).
oreover,  the  properties  of  carbogen  have  been  used  in
euro-oncology  to  increase  the  oxygenation  of  brain  tumors
nd  their  radiosensitivity  [245,246,276—278].  In  spite  of  the
ncouraging  experimental  results  [279],  the  evaluation  of
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he  effects  of  radiosensitization  by  carbogen  and  nicotin-
mide  have  been  disappointing  [276,277].  However,  we  can
ebate  the  possibility  of  a  better  selection  of  patients,  in
articular  on  the  basis  of  imaging  of  the  tumor  response  to
adiosensitizing  agents  [276].
onclusion
o  conclude,  the  functional  imaging  of  cerebral  perfusion  is
sed  for  the  mapping  of  the  three  main  properties  of  brain
icrovascularization:  neurovascular  coupling,  vasoreactiv-
ty  to  circulating  gases  and  autoregulation  of  the  perfusion
ressure.  BOLD  fMRI  of  the  cerebral  vasoreactivity  to  CO2 is
ncreasingly  used.  fMRI  of  the  cerebral  vasoreactivity  may  be
sed  to  estimate  the  vascular  reserve  and  risk  of  a  stroke  in
teno-occlusive  disease  in  order  to  improve  the  treatment.
MRI  of  cerebral  vasoreactivity  detects  early  alterations  in
lzheimer’s  disease  and  the  subjects  at  risk.  fMRI  of  cerebral
asoreactivity  may  be  used  to  better  interpret  the  results  in
MRI  activation,  in  particular  before  neurosurgery.
Therefore,  it’s  only  a  question  of  time,  access  and  prop-
gation  of  techniques.  Most  likely,  the  coming  decade  will
onﬁrm  the  development  of  the  clinical  applications  of  the
unctional  imaging  of  perfusion  for  brain  and  heart  diseases,
s  well  as  for  other  organs.
TAKE-HOME  MESSAGES
• Functional  imaging  of  cerebral  perfusion  is
used  in  the  mapping  of  the  3  main  properties
of  brain  microvascularization:  neurovascular
coupling,  vasoreactivity  to  circulating  gases  and
autoregulation  of  the  perfusion  pressure.
• BOLD  fMRI  of  cerebral  vasoreactivity  to  CO2 is
increasingly  used.
• fMRI of  cerebral  vasoreactivity  may  be  used  to
estimate  the  vascular  reserve  and  the  risk  of  stroke
in  steno-occlusive  disease  in  order  to  improve  the
treatment.
• fMRI  of  cerebral  vasoreactivity  detects  early
alterations  in  Alzheimer’s  disease  and  subjects  at
risk.
• fMRI  of  cerebral  vasoreactivity  may  be  used  to  better
interpret  the  results  in  fMRI  activation,  in  particular
before  neurosurgery.
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